MLC1501 Study Assessing Efficacy in STROke Recovery

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 540 participants.

Also called NCT05046106

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 540 participants (planned count) (from the registry)
Sponsor
Moleac Pte Ltd. (from the registry)
Registry
  • NCT NCT05046106
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT05046106. Randomized; quadruple masking; primary purpose treatment. Start 2025-01 (anticipated); primary completion 2028-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MLC1501 Study Assessing Efficacy in STROke Recovery
Acronym
MAEStro
Condition
Stroke
Condition
Stroke, Ischemic
Condition
Strokes Thrombotic
Condition
Stroke Sequelae
Condition
Stroke, Cardiovascular
Condition
Stroke, Embolic
Condition
Stroke, Cryptogenic
Intervention (Drug)
MLC1501
Intervention (Other)
Placebo
Lead sponsor
Moleac Pte Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05046106
Content hash
abeaab7b632e5517de980070dd683fe5004ed84e354a946da0f2dd18dc251e50